For the quarter ending 2026-03-31, JSPR has $21,184K in assets. $17,784K in debts. $14,144K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 14,144 | 28,692 | 50,899 | 39,510 |
| Prepaid expenses and other current assets | 6,148 | 5,953 | 3,665 | 3,456 |
| Total current assets | 20,292 | 34,645 | 54,564 | 42,966 |
| Property and equipment, gross | 4,916 | 4,916 | 5,007 | - |
| Less accumulated depreciation and amortization | 4,835 | 4,814 | 3,905 | - |
| Property and equipment, net | 81 | 102 | 1,102 | 1,331 |
| Operating lease right-of-use assets | 317 | 502 | 1,236 | 1,560 |
| Restricted cash | 417 | 417 | 417 | 417 |
| Other non-current assets | 77 | 113 | 150 | 192 |
| Total assets | 21,184 | 35,779 | 57,469 | 46,466 |
| Accounts payable | 2,439 | 6,220 | 9,166 | 8,034 |
| Operating lease liabilities | 757 | 1,235 | 1,703 | 1,954 |
| Accrued expenses and other current liabilities | 5,800 | 5,745 | 10,172 | 10,512 |
| Total current liabilities | 8,996 | 13,200 | 21,041 | 20,500 |
| Warrant liability | 6,524 | 16,164 | 22,593 | - |
| Other non-current liabilities | 2,264 | 2,264 | 2,264 | 2,264 |
| Non-current portion of operating lease liabilities | - | - | - | 201 |
| Total liabilities | 17,784 | 31,628 | 45,898 | 22,965 |
| Common stock 0.0001 par value 492,000,000 shares authorized at march 31, 2026 and december 31, 2025 27,996,819 shares issued and outstanding at march 31, 2026 and december 31, 2025 | 3 | 3 | 3 | 2 |
| Additional paid-in capital | 321,241 | 320,818 | 319,137 | 312,332 |
| Accumulated deficit | -317,844 | -316,670 | -307,569 | -288,833 |
| Total stockholders equity | 3,400 | 4,151 | 11,571 | 23,501 |
| Total liabilities and stockholders equity | 21,184 | 35,779 | 57,469 | 46,466 |
Jasper Therapeutics, Inc. (JSPR)
Jasper Therapeutics, Inc. (JSPR)